≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_CERVIX_UTERI_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C53
  • Hospital discharge: ICD-9 — 180
  • Hospital discharge: ICD-8 — 180
  • Cause of death: ICD-10 — C53
  • Cause of death: ICD-9 — 180
  • Cause of death: ICD-8 — 180
  • Cancer registry: Topography ICD-O-3 — C53
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

924

4. Check minimum number of events

None

924

5. Include endpoints

None

924

6. Filter based on genotype QC (FinnGen only)

924

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 924 924 -
Unadjusted period prevalence (%) 0.31 0.31 -
Median age at first event (years) 42.71 42.71 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
519
Matched controls
5190
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
128
Kela drug reimbursment
Cancers of female genital organs
2531.5
184.9
168
*
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
+∞
184.7
166
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
183.5
165
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
157.5
143
*
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
144.7
132
*
ULA02
NOMESCO Finland
Kolposcopy
12.0
125.4
275
446
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
18.0
120.1
201
176
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
10.5
114.6
272
492
H02AB02
ATC
dexamethasone; systemic
57.5
108.4
127
29
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1248.3
107.3
101
*
WF002
NOMESCO Finland
Radical radiotherapy
605.6
103.4
99
*
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
+∞
102.6
95
*
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
9.2
96.0
238
435
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
93.6
87
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
11.1
93.3
198
272
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
+∞
80.3
75
*
ZXC96
NOMESCO Finland
Robot assisted procedure
145.7
72.0
75
6
A04AA55
ATC
palonosetron, combinations; systemic
791.3
71.9
69
*
LCD30
NOMESCO Finland
Radical hysterectomy
+∞
69.3
65
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
69.3
65
*
XX3DW
NOMESCO Finland
Time consuming IT work
16.5
68.4
114
87
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
65.3
68.0
78
14
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
60.9
67.3
78
15
A03FA01
ATC
metoclopramide; systemic, rectal
6.4
64.6
204
477
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
62.8
59
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
61.7
58
*
LEB00
NOMESCO Finland
Biopsy of vagina
29.8
58.5
79
31
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
57.4
54
*
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
57.4
54
*
A04AA01
ATC
ondansetron; systemic, rectal
18.5
57.1
90
58
WF003
NOMESCO Finland
Adjuvant radiotherapy
611.0
56.7
55
*
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
+∞
56.3
53
*
JN4BD
NOMESCO Finland
Extensive body CT
14.9
55.6
96
78
B01AB10
ATC
tinzaparin; parenteral
12.6
55.1
103
100
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
53.0
50
*
A04AA02
ATC
granisetron; systemic, transdermal
153.4
52.9
55
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
288.2
52.1
52
*
LDA10
NOMESCO Finland
Curettage of cervix uteri
8.9
52.0
119
168
8140/3-C53.0
ICD-O-3
Adenocarcinoma, NOS, of endocervix
+∞
52.0
49
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
24.8
51.4
73
34
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
282.1
51.0
51
*
8076/3-C53.9
ICD-O-3
Squamous cell carcinoma, microinvasive of cervix uteri
+∞
50.9
48
*
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
+∞
50.9
48
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
49.8
47
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
48.7
46
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
476.6
44.9
44
*
A04AD12
ATC
aprepitant; systemic
476.6
44.9
44
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
44.4
42
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
11.3
43.6
85
88
121
Kela drug reimbursment
Severe hypofunction of sexual glands
16.4
42.2
69
48
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.8
40.5
158
435
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
40.1
38
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
40.1
38
*
C53.0
ICD-10 Finland
Malignant neoplasm: Endocervix
+∞
40.1
38
*
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
91.3
38.4
42
5
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
394.2
37.5
37
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
36.9
35
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
382.6
36.4
36
*
B01AB05
ATC
enoxaparin; parenteral
3.6
36.4
217
863
8070/3-C53.1
ICD-O-3
Squamous cell carcinoma, NOS, of exocervix
+∞
35.8
34
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.5
35.3
226
944
C53.09
ICD-10 Finland
Malignant tumor of endocervix, unspecified histology
+∞
34.8
33
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
29.5
34.3
46
17
C53.1
ICD-10 Finland
Malignant neoplasm: Exocervix
+∞
33.7
32
*
Z51.5
ICD-10 Finland
Palliative care
20.3
33.4
50
27
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
30.5
29
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
62.3
30.5
35
6
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
164.5
30.0
31
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
29.5
28
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
296.7
28.0
28
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
296.7
28.0
28
*
C53.90
ICD-10 Finland
Malignant tumor in unspecified localization in cervix uteri without histology
+∞
27.3
26
*
JN5JS
NOMESCO Finland
Extensive PET-MRI of body metabolism
+∞
27.3
26
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
27.3
26
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
6.9
26.5
69
113
WZC30
NOMESCO Finland
Teaching
4.9
26.5
94
225
C53.10
ICD-10 Finland
Malignant tumor of the exocervix without histology
+∞
26.3
25
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
273.5
25.9
26
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
25.4
264
1434
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
25.2
24
*
1800A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Endocervix
+∞
25.2
24
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
51.0
24.5
29
6
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
8.0
24.5
57
79
C53.99
ICD-10 Finland
Malignant tumor in unspecified localization in cervix, unspecified histology
+∞
24.1
23
*
C53
ICD-10 Finland
Malignant neoplasm of cervix uteri
+∞
24.1
23
*
8310
FHL
Radical hysterectomy (includes lymph node removal)
+∞
24.1
23
*
WW500
NOMESCO Finland
Blood transfusion
11.9
23.4
43
39
18099
ICD-8 Finland
Malignant neoplasm of cervix uteri
+∞
23.1
22
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
23.1
22
*
8070/3-C53.0
ICD-O-3
Squamous cell carcinoma, NOS, of endocervix
+∞
23.1
22
*
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
8.3
22.7
51
67
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
11.3
21.3
40
38
130
Kela drug reimbursment
Malignant tumour
+∞
21.0
20
*
L03AA02
ATC
filgrastim; parenteral
114.6
20.7
22
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
114.6
20.7
22
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
43.6
20.6
25
6
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.4
20.6
37
32
C53.19
ICD-10 Finland
Malignant tumor of the exocervix, unspecified histology
+∞
19.9
19
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
+∞
19.9
19
*
C53.81
ICD-10 Finland
Overall squamous cell carcinoma of the cervix uteri
+∞
19.9
19
*
115
Kela drug reimbursment
Breast cancer
+∞
19.9
19
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
18.9
18
*
LAG11
NOMESCO Finland
Laparoscopic oophoropexy
+∞
18.9
18
*
N02AA05
ATC
oxycodone; systemic
3.9
18.8
83
242
UKC02
NOMESCO Finland
Cystoscopy
3.7
18.8
87
265
L03AA14
ATC
lipegfilgrastim; parenteral
196.8
18.7
19
*
LCA06
NOMESCO Finland
Biopsy of endometrium
2.9
18.3
124
500
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
17.8
17
*
JN4AD
NOMESCO Finland
Body CT examination
8.6
17.1
37
46
C53.91
ICD-10 Finland
Squamous cell carcinoma in an unspecified location in the cervix
+∞
16.8
16
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
16.8
16
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
16.8
16
*
1801A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Exocervix
+∞
16.8
16
*
ZX120
NOMESCO Finland
Intravenous
4.5
16.4
60
147
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
15.2
133
616
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
10.9
14.9
28
27
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
25.9
14.8
20
8
WX402
NOMESCO Finland
General anaesthesia
2.9
14.8
101
402
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.9
14.1
35
54
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
77.2
13.6
15
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.6
13
*
C53.89
ICD-10 Finland
Overall malignant tumor of the cervix uteri, unspecified histology
+∞
13.6
13
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
13.6
13
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.5
13.3
39
75
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
41.2
13.2
16
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
17.3
13.1
20
12
L01BC06
ATC
capecitabine; oral
+∞
12.5
12
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
12.5
12
*
C53.9
ICD-10 Finland
Malignant neoplasm: Cervix uteri, unspecified
+∞
12.5
12
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
12.5
12
*
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
133.1
12.5
13
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
133.1
12.5
13
*
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
6.0
12.1
33
58
KA1FN
NOMESCO Finland
Isotope renography
27.4
12.1
16
6
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
7.1
12.1
29
43
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
11.9
53
155
JN3AD
NOMESCO Finland
Abdominal CT examination
4.0
11.8
47
125
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
8140/3-C53.1
ICD-O-3
Adenocarcinoma, NOS, of exocervix
+∞
11.5
11
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
122.6
11.5
12
*
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
122.6
11.5
12
*
LBE10
NOMESCO Finland
Bilateral salpingectomy
25.7
11.2
15
6
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
5.7
11.1
31
57
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
10.9
49
145
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
6.6
10.8
27
43
HA1AA
NOMESCO Finland
X-ray mammography
4.4
10.7
38
91
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
112.2
10.5
11
*
JN5KS
NOMESCO Finland
Very extensive PET-MRI of body metabolism
+∞
10.4
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.4
10
*
C53.92
ICD-10 Finland
Adenocarcinoma in an unspecified location in the cervix
+∞
10.4
10
*
X75
ICPC
Malignant neoplasm cervix
+∞
10.4
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.4
10
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
10.4
10
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.5
10.3
36
85
N87.9
ICD-10 Finland
Dysplasia of cervix uteri, unspecified
20.5
9.8
14
7
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.4
9.8
25
41
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.3
9.6
18
18
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
9.4
129
722
E89.4
ICD-10 Finland
Postprocedural ovarian failure
+∞
9.4
9
*
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
+∞
9.4
9
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
9.4
9
*
KC1GB
NOMESCO Finland
Cystography with X-ray
+∞
9.4
9
*
C539, 8085, 3
ICD-O-3
NA
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
C53.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of cervix uteri
+∞
9.4
9
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
9.4
9
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
9.4
9
*
N95.0
ICD-10 Finland
Postmenopausal bleeding
2.7
9.3
65
262
HAB40
NOMESCO Finland
Wedge excision of mammary gland
15.9
9.1
14
9
B02AA02
ATC
tranexamic acid; systemic
2.1
8.9
116
634
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
4.6
8.7
29
66
XX1XW
NOMESCO Finland
Extensive written report from radiologist
6.2
8.5
22
37
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
8.5
61
250
KBV00
NOMESCO Finland
Insertion of stent into ureter
20.4
8.5
12
6
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.4
8
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
8.4
8
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
8.4
8
*
D39.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other female genital organs
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
18011
ICD-8 Finland
NA
+∞
8.4
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
8.4
8
*
N02BE01
ATC
paracetamol; systemic, rectal
2.1
8.3
448
3913
B03XA02
ATC
darbepoetin alfa; parenteral
11.9
8.1
14
12
A06AH03
ATC
naloxegol; oral
33.9
8.1
10
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
7.9
62
266
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.4
7.6
26
61
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
7.6
80
398
LDW96
NOMESCO Finland
Other operation on cervix uteri
81.2
7.4
8
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.1
7.3
92
491
1XC07
NOMESCO Finland
NA
+∞
7.3
7
*
N88.9
ICD-10 Finland
Noninflammatory disorder of cervix uteri, unspecified
+∞
7.3
7
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
8380/3-C53.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of cervix uteri
+∞
7.3
7
*
C55
ICD-10 Finland
Malignant neoplasm of uterus, part unspecified
+∞
7.3
7
*
LAG10
NOMESCO Finland
Oophoropexy
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
8560/3-C53.9
ICD-O-3
Adenosquamous carcinoma of cervix uteri
+∞
7.3
7
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
7.3
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
20.3
7.2
10
5
JN4CD
NOMESCO Finland
Very extensive body CT
8.1
7.1
15
19
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
9.0
7.1
14
16
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.4
7.0
58
258
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.8
6.9
44
168
LBE01
NOMESCO Finland
Laparoscopic salpingectomy
3.8
6.9
27
73
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
11.1
6.8
12
11
KBV10
NOMESCO Finland
Removal of stent from ureter
9.5
6.8
13
14
KA3EB
NOMESCO Finland
Antegrade pyelography
40.6
6.8
8
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
40.6
6.8
8
*
LDC00
NOMESCO Finland
Conisation of cervix uteri using knife
40.6
6.8
8
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
6.6
87
473
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
6.5
48
198
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.4
6.5
22
52
WX892
NOMESCO Finland
Monitored bed care
2.9
6.5
38
139
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
70.7
6.4
7
*
N82.0
ICD-10 Finland
Vesicovaginal fistula
70.7
6.4
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
70.7
6.4
7
*
A79
ICPC
Malignancy NOS
70.7
6.4
7
*
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
18.3
6.3
9
5
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
6.3
6
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
6.3
6
*
8010/3-C53.9
ICD-O-3
Carcinoma, NOS, of cervix uteri
+∞
6.3
6
*
X77
ICPC
Malignant neopl genital female other
+∞
6.3
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.3
6
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
6.3
6
*
WF099
NOMESCO Finland
Other radiotherapy
+∞
6.3
6
*
C53.80
ICD-10 Finland
Overall malignant tumor of the cervix uteri without histology
+∞
6.3
6
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
27.0
6.2
8
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
6.0
90
513
JAH00
NOMESCO Finland
Laparotomy
5.7
6.0
16
29
TKC20
NOMESCO Finland
Catheterisation of bladder
2.8
6.0
36
134

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
228
203
14.58
227.38
1.5
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
266
454
7.82
158.70
5.4
1.5
u/ml
113.5
23.9
0.93
261
434
(3012095) Magnesium [Moles/volume] in Serum or Plasma
302
919
4.40
90.16
5.2
2.2
mmol/l
0.8
0.8
13.88
295
850
(4281824)
74
48
16.67
86.30
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
183
439
4.95
72.74
2.1
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
423
2000
3.06
59.54
2.3
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
38
12
32.98
58.66
1.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
572
3292
2.94
54.50
5.1
3.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
99
177
6.14
54.03
1.9
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
507
2798
2.80
51.30
2.6
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
507
2849
2.73
48.69
5.9
3.5
g/l
34.2
36.2
10.29
476
2615
(3023368) Bacteria identified in Blood by Culture
314
1437
2.80
44.42
5.6
3.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
387
2067
2.50
38.91
2.8
1.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
534
3340
2.42
37.24
8.1
3.3
umol/l
9.2
10.1
1.21
513
3092
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
113
311
4.00
36.57
3.5
1.4
ug/l
5.2
2.6
1.41
90
228
(3013650) Neutrophils [#/volume] in Blood by Automated count
598
4035
2.37
33.59
14.2
6.3
e9/l
4.0
4.1
0.34
554
3500
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
34
31
11.35
32.15
1.0
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
325
1728
2.36
31.66
9.8
4.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
38
43
9.17
30.87
2.2
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
423
2589
2.17
28.56
4.1
3.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
354
2022
2.22
28.44
1.6
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
348
1998
2.19
27.38
3.7
2.9
e6/l
94.7
71.0
0.20
280
1498
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
285
1561
2.19
24.80
2.7
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
401
2511
2.05
24.43
4.4
3.4
e6/l
171.6
99.7
1.07
306
1650
(3000850) Epithelial cells [#/volume] in Urine
265
1425
2.21
24.03
2.6
2.4
e6/l
10.0
8.6
0.38
225
1243
(3015377) Calcium [Moles/volume] in Serum or Plasma
380
2346
2.05
23.95
5.0
2.0
mmol/l
2.4
2.4
0.48
348
2000
(3030467) Casts [#/volume] in Urine by Automated count
315
1839
2.08
22.91
3.7
2.8
e6/l
0.5
0.4
0.36
251
1369
(3032080) INR in Blood by Coagulation assay
386
2436
2.00
22.53
8.5
8.1
inr
1.2
1.2
0.45
127
739
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
699
5492
2.12
21.07
10.1
5.1
u/l
88.9
73.8
3.19
672
5071
(36304419) Bacteria [Presence] in Urine
308
1831
2.02
20.97
3.5
2.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
672
5210
2.06
20.92
6.1
4.6
e6/l
3799.0
3263.3
0.10
21
63
(3020779) Urea [Moles/volume] in Serum or Plasma
106
415
2.76
19.03
9.1
5.9
mmol/l
10.6
9.2
1.12
98
395
(3033658) Prothrombin time (PT) actual/Normal
276
1627
1.99
18.91
4.6
2.9
%
96.2
94.9
0.35
271
1568
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
110
448
2.65
18.26
2.1
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
229
1305
2.00
17.03
3.2
2.5
mosm/kgh2o
512.4
516.9
0.12
201
1103
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
185
999
2.07
15.86
3.6
2.5
e6/l
6.2
4.7
0.54
111
499
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
199
1107
2.02
15.71
3.4
2.4
e6/l
1.6
1.8
0.15
117
605
(3000991) Gas panel - Venous blood
99
413
2.56
15.60
9.5
5.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
520
3904
1.76
15.49
6.4
5.1
estimate
0.0
0.0
0.50
112
683
(3029937) Albumin [Presence] in Urine by Test strip
313
2029
1.82
15.48
5.2
4.0
estimate
0.0
0.0
0.80
111
679
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
467
3403
1.75
15.44
8.0
4.9
mmol/l
1.2
1.2
1.85
382
2865
(3009261) Glucose [Presence] in Urine by Test strip
522
3940
1.75
15.10
4.9
3.7
estimate
0.0
0.0
1.08
114
675
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
423
3010
1.75
15.10
6.7
4.4
mmol/l
1.2
1.2
2.05
394
2652
(3013826) Glucose [Moles/volume] in Serum or Plasma
531
4028
1.75
15.08
5.2
3.8
mmol/l
6.6
6.6
0.09
504
3668
(3011397) Hemoglobin [Presence] in Urine by Test strip
290
1854
1.82
14.90
4.2
3.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
126
600
2.27
14.80
3.7
3.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
15
13
11.71
14.45
2.1
1.3
ug/l
14.2
16.4
0.58
15
13
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
132
663
2.16
13.56
3.0
2.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
44
125
3.65
13.50
3.0
3.1
u/ml
0.3
0.4
1.19
27
79
(3002256) Pathology report gross observation
124
613
2.18
13.25
1.3
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
301
2005
1.74
13.15
4.8
2.9
ph
7.4
7.4
0.64
70
327
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
163
904
1.98
12.78
6.9
6.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
503
3877
1.65
12.44
4.9
3.7
estimate
0.0
0.0
0.50
110
680
(3002032) Base excess in Venous blood by calculation
108
521
2.21
12.24
6.0
2.9
mmol/l
1.5
2.2
0.98
90
417
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
16
6
27.09
12.07
3.4
1.0
u/ml
87.8
14.8
—
16
6
(3016502) Oxygen saturation in Arterial blood
108
533
2.16
11.55
6.3
6.7
%
95.8
95.7
0.07
101
515
(40768806) Pleura Pathology biopsy report
15
18
8.45
11.51
1.2
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
647
5387
1.67
11.23
6.2
4.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
80
354
2.38
11.08
3.7
5.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
120
628
2.05
11.00
6.4
6.1
mmol/l
1.4
1.4
0.08
85
482
(3012544) pH of Venous blood
108
544
2.12
10.95
5.9
3.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
44
144
3.16
10.87
2.3
1.7
—
—
—
0
0
(40758358) Immune stain study
10
0
+∞
10.43
1.0
0.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
118
629
2.00
10.26
6.3
6.1
kpa
12.1
12.1
0.03
109
600
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
118
629
2.00
10.26
6.3
6.1
kpa
5.1
5.1
0.01
109
602
(3003458) Phosphate [Moles/volume] in Serum or Plasma
136
763
1.92
10.19
7.0
3.9
mmol/l
1.0
1.0
0.18
127
698
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
60
251
2.49
9.40
6.7
2.9
mmol/l
23.4
24.3
0.86
52
221
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
306
2203
1.58
9.23
3.9
2.2
u/l
54.0
56.6
0.76
295
2010
(3021589) Normoblasts [#/volume] in Blood
415
3210
1.53
9.03
11.6
7.7
e9/l
0.0
0.0
0.37
353
2621
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
683
7587
0.62
8.85
3.9
4.2
mmol/l
4.9
4.8
0.71
649
7062
(3012441) Differential panel - Pleural fluid
15
25
6.08
8.67
1.3
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
46
176
2.70
8.64
1.5
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
8
16.46
8.56
1.2
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
155
954
1.75
8.55
3.3
2.2
g/l
2.2
2.4
4.23
139
881
(3007853) Bacteria identified in Skin by Aerobe culture
133
786
1.81
8.41
1.7
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
680
7535
0.63
8.21
3.8
4.2
mmol/l
1.6
1.6
0.32
644
6981
(40761536) Microorganisms panel - Urine sediment
109
611
1.89
8.15
5.2
3.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
139
842
1.77
8.08
2.0
1.9
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
15
27
5.63
8.04
1.3
1.1
e6/l
18567.0
271658.2
—
9
13
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
35
122
2.94
7.82
4.0
1.9
u/ml
448.3
67.2
0.42
29
100
(3023199) Leukocytes [#/volume] in Pleural fluid
16
32
5.07
7.68
1.3
1.1
e6/l
761.7
1178.4
0.50
11
24
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
309
2305
1.51
7.65
4.4
2.5
u/l
35.3
28.2
1.60
294
2206
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
12
18
6.74
7.62
1.1
1.1
u/l
157.9
241.1
0.52
12
18
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
26
77
3.45
7.57
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
193
1300
1.61
7.50
4.0
2.2
mmol/l
2.5
2.4
5.49
167
1122
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
138
854
1.72
7.42
3.4
2.3
%
20.4
22.8
1.36
121
713
(3035637) Corticotropin [Mass/volume] in Plasma
24
69
3.54
7.30
2.0
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
452
3671
1.45
7.15
6.1
5.3
e9/l
0.0
0.0
4.23
405
3179
(3001604) Monocytes [#/volume] in Blood
448
3651
1.44
6.85
6.1
5.3
e9/l
0.6
0.5
0.18
403
3169
(3019198) Lymphocytes [#/volume] in Blood
460
3771
1.44
6.79
6.1
5.3
e9/l
1.6
1.9
14.83
415
3342
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
380
3010
1.45
6.75
5.5
3.9
—
—
—
0
0
(3020891) Body temperature
50
226
2.28
6.66
4.3
4.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
302
2296
1.47
6.62
6.0
5.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
463
3813
1.43
6.60
6.2
5.5
e9/l
0.2
0.2
1.62
418
3366
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
827
7655
1.77
6.57
21.2
11.1
mg/l
27.8
19.6
8.54
722
5834
(3019150) Specific gravity of Urine by Refractometry
239
1737
1.51
6.54
5.0
4.2
kg/l
1.0
1.0
0.70
19
260
(3022096) Basophils/100 leukocytes in Blood
407
3278
1.43
6.54
6.1
5.5
%
0.6
0.7
3.30
389
3012
(3022948) Iron [Moles/volume] in Serum or Plasma
161
1075
1.60
6.43
3.3
2.2
umol/l
12.2
13.8
1.55
148
984
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
151
996
1.62
6.33
2.1
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
90
515
1.83
6.31
3.9
2.4
mmol/l
1.2
1.2
0.11
84
415
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
712
7720
0.66
6.15
4.2
4.7
mmol/l
2.9
2.8
0.43
669
7152
(3044889) 12 lead EKG panel
585
5065
1.42
6.06
3.6
3.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
659
7247
0.68
6.05
3.5
3.7
mmol/l
1.3
1.2
2.91
620
6650
(3019069) Monocytes/100 leukocytes in Blood
418
3419
1.41
5.99
6.4
5.6
%
8.6
8.0
3.16
401
3169
(3027945) Reticulocytes/100 erythrocytes in Blood
106
650
1.71
5.88
2.9
2.3
%
1.9
1.8
0.27
93
571
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
111
691
1.69
5.82
2.2
1.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
415
3402
1.40
5.82
6.2
5.4
%
2.6
2.8
0.97
397
3129
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
37
157
2.41
5.71
1.4
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
829
7741
1.69
5.56
22.8
12.5
mmol/l
139.3
139.7
4.87
814
7513
(3023103) Potassium [Moles/volume] in Serum or Plasma
830
7760
1.68
5.45
23.0
12.6
mmol/l
3.9
3.9
0.38
815
7515
(3002030) Lymphocytes/100 leukocytes in Blood
424
3528
1.37
5.26
6.2
5.5
%
25.3
29.0
9.62
409
3256
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
51
258
2.03
5.17
9.8
9.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
121
797
1.60
5.08
1.5
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
107
688
1.63
4.96
2.1
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
637
6981
0.72
4.93
5.0
5.3
mmol/mol
38.7
39.1
0.38
602
6497
(3018010) Neutrophils/100 leukocytes in Blood
418
3496
1.36
4.91
6.2
5.3
%
60.0
57.1
4.97
402
3239
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
71
414
1.77
4.72
2.1
2.0
u/l
583.1
4155.8
2.33
34
177
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
113
2.43
4.34
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
24
95
2.57
4.32
1.3
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
22
4.58
4.31
2.2
3.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
762
7076
1.44
4.24
19.6
9.6
ml/min/173m2
81.2
82.5
0.75
656
5640
(3045788) Cell count panel - Pleural fluid
11
27
4.11
4.17
1.5
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
114
776
1.54
4.16
16.0
23.8
inr
1.2
1.3
0.19
20
120
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
14
6.48
3.99
1.7
2.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
85
546
1.61
3.98
2.6
2.0
ml/min/173m2
62.5
70.0
0.98
40
221
(3023323) Follitropin [Units/volume] in Serum or Plasma
85
547
1.61
3.95
1.2
1.3
iu/l
49.9
26.5
4.18
68
474
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
222
1731
1.37
3.93
2.0
1.7
mg/l
1.8
1.0
1.14
177
1281
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
105
713
1.53
3.88
2.6
2.0
umol/l
6.3
5.0
0.83
89
594
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
28
126
2.26
3.86
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
28
126
2.26
3.86
1.2
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
29
3.83
3.81
1.6
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
94
629
1.55
3.71
2.8
2.0
u/l
38.5
35.5
0.15
80
519
(3023520) Reticulocytes [#/volume] in Blood
72
454
1.64
3.65
3.3
2.4
e9/l
71.9
73.0
0.09
49
341
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
30
3.70
3.64
1.6
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
25
110
2.31
3.64
1.2
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
78
502
1.60
3.64
1.5
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
59
354
1.71
3.60
2.0
1.6
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
7
9
7.83
3.56
1.9
2.9
%
55.4
58.4
—
7
9
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
30
145
2.10
3.51
1.3
1.4
nmol/l
0.3
0.4
0.22
17
127
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
48
274
1.79
3.48
4.0
2.2
%
1.4
1.1
1.09
48
274
(1616796) Gas panel - Central venous blood
24
106
2.30
3.48
4.4
2.9
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
64
2.69
3.41
1.4
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
310
2585
1.30
3.40
3.6
3.4
ng/l
25.0
44.7
0.66
194
1554
(3010421) pH of Blood
30
150
2.03
3.23
4.5
3.2
ph
7.4
7.4
0.17
24
117
(3000570) Elastase.pancreatic [Mass/mass] in Stool
38
207
1.87
3.21
1.3
1.4
ug/g
308.4
309.5
0.01
23
113
(3012501) Base excess in Blood by calculation
25
117
2.17
3.18
4.8
3.5
mmol/l
2.7
2.8
0.10
14
82
(40767503) Oxygen content in Capillary blood by calculation
23
105
2.22
3.11
2.1
2.1
%
17.2
16.8
0.20
12
48
(3051387) C reactive protein [Mass/volume] in Capillary blood
30
153
1.99
3.07
2.6
4.0
mg/l
32.5
24.3
0.45
14
100
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
8
7.54
3.06
6.2
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
57
357
1.64
3.00
4.7
2.8
g/l
123.4
128.2
0.95
57
344
(40760892) CBC W Ordered Manual Differential panel - Blood
213
1719
1.31
2.93
4.1
3.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
41
2.95
2.86
1.4
3.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
34
186
1.86
2.86
2.8
3.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
59
2.57
2.79
1.8
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
131
2.01
2.77
1.8
2.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
161
2024
0.75
2.74
1.7
1.6
mmol/l
1.4
1.3
1.20
138
1725
(3027273) Bicarbonate [Moles/volume] in Venous blood
48
295
1.66
2.74
4.9
2.9
mmol/l
25.6
25.5
0.05
48
285
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
60
885
0.66
2.60
3.7
4.3
%
32.2
33.6
0.52
49
596
(3015235) Bicarbonate [Moles/volume] in Capillary blood
24
121
2.01
2.57
3.3
3.1
mmol/l
23.7
25.4
1.25
24
109
(3001019) Free T4 and TSH panel - Serum or Plasma
34
571
0.58
2.55
1.7
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
15
62
2.44
2.55
2.4
3.0
%
3.1
1.4
0.97
15
45
(3051611) Lipemic interference index of Serum or Plasma
14
58
2.44
2.37
2.6
2.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
55
364
1.54
2.36
1.9
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
687
6456
1.25
2.30
25.8
13.3
%
14.0
13.6
8.84
674
6291
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
23
3.50
2.27
3.1
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
48
311
1.57
2.26
4.1
3.0
ph
7.4
7.4
—
6
40
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
47
303
1.58
2.26
4.0
2.9
mmol/l
1.9
1.9
0.04
31
219
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
18
3.91
2.25
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
99
742
1.37
2.24
1.4
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
53
776
0.66
2.23
1.3
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
37
226
1.66
2.21
4.2
6.3
%
1.7
1.6
0.24
32
214
(3043238) Trisomy 21 risk [Likelihood] in Fetus
14
295
0.47
2.20
1.6
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
41
258
1.62
2.18
1.3
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
6
14
4.31
2.15
1.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
40
252
1.61
2.13
1.3
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
20
368
0.53
2.11
1.6
1.5
—
—
—
0
0
(1002224) Polysomnography panel
16
316
0.50
2.10
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
40
253
1.61
2.10
1.3
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
9
31
2.92
2.07
1.1
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
14
288
0.48
2.07
1.6
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
10
5.02
2.07
1.0
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
110
1.93
2.07
4.8
2.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
24
132
1.84
2.05
2.0
2.0
g/l
133.5
131.8
0.13
17
100
(3005033) Fetal Nuchal fold Thickness US
14
286
0.48
2.04
1.6
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
34
209
1.65
2.00
3.7
2.4
g/l
0.2
0.3
0.61
14
56
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
36
225
1.62
1.99
2.0
1.8
g/l
1.4
1.5
0.51
28
198
(3011436) Histone Ab [Units/volume] in Serum
6
16
3.77
1.93
1.2
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
19
344
0.54
1.92
1.5
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
221
1882
1.23
1.90
2.8
2.8
ng/l
2754.1
1192.5
1.29
194
1572
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
19
343
0.54
1.90
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
74
989
0.73
1.90
1.7
1.9
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
19
342
0.55
1.88
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
19
342
0.55
1.88
1.5
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
41
608
0.66
1.87
1.4
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
39
253
1.57
1.87
1.9
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
24
403
0.58
1.86
1.6
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
17
86
2.00
1.86
2.4
2.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
33
511
0.63
1.84
1.3
1.3
—
35.9
—
0
19
(3017181) Myelocytes/100 leukocytes in Blood
73
540
1.38
1.82
3.5
3.8
%
0.5
0.8
0.48
26
95
(3016650) Hepatitis A virus Ab [Presence] in Serum
20
109
1.85
1.78
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
59
423
1.42
1.77
1.7
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
36
233
1.57
1.75
1.7
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
160
1327
1.25
1.75
1.6
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
245
2126
1.21
1.74
4.9
3.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
36
2.51
1.74
1.4
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
20
110
1.84
1.74
1.9
1.3
mmol/l
62.5
64.3
0.06
15
93
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
716
7462
0.82
1.72
4.2
4.3
mmol/l
5.9
5.8
0.66
666
6848
(3025941) Bacteria identified in Stool by Culture
64
470
1.39
1.68
1.4
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
35
228
1.56
1.67
4.5
3.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
7
25
2.81
1.65
1.4
1.8
mg/l
3.1
4.5
—
7
25
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
14
3.58
1.61
1.0
3.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
40
271
1.50
1.61
2.3
2.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
121
1.75
1.59
1.5
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
20
3.01
1.58
2.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
20
3.01
1.58
2.2
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
360
0.60
1.58
1.7
1.6
mg/l
1.4
2.8
2.65
12
244
(3028626) Oxygen [Partial pressure] in Capillary blood
19
107
1.79
1.55
2.6
2.6
kpa
8.1
8.1
0.06
19
101
(3019832) Treponema pallidum Ab [Presence] in Serum
79
1010
0.76
1.53
1.5
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
138
1.68
1.53
3.9
3.5
%
59.2
58.8
0.04
23
138
(3020650) Glucose [Presence] in Urine
5
15
3.35
1.52
1.2
2.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
719
7466
0.83
1.49
5.6
5.4
mu/l
1.9
2.0
0.44
667
6948
(1761482) Bacteria [#/volume] in Urine by Culture
29
187
1.57
1.47
4.6
4.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
66
501
1.34
1.44
3.5
3.9
%
0.0
1.2
0.54
23
77
(3047189) Immunofixation for 24 hour Urine
5
16
3.14
1.44
3.0
1.1
—
—
—
0
0
(44790048)
12
59
2.05
1.44
1.4
1.4
—
—
—
0
0
(44790047)
12
59
2.05
1.44
1.4
1.4
—
—
—
0
0
(44790049)
12
59
2.05
1.44
1.4
1.4
—
—
—
0
0
(44806118)
12
59
2.05
1.44
1.4
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
521
4872
1.16
1.44
3.3
2.8
u/l
59.9
36.3
2.53
486
4552
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
118
1.71
1.42
1.2
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
40
2.26
1.40
1.4
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
32
214
1.51
1.40
1.4
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
104
1.75
1.37
1.6
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
220
1932
1.18
1.36
2.3
2.2
mg/l
3.3
2.9
1.23
189
1657
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
136
1.63
1.33
3.5
3.3
e9/l
3.6
4.3
0.77
22
136
(36660697) Celiac disease serology panel - Serum
53
699
0.74
1.30
1.1
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
145
1.60
1.30
1.5
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
34
2.36
1.29
1.1
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
67
521
1.31
1.27
3.6
3.9
%
0.1
0.1
0.17
24
88
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
107
1.70
1.26
1.1
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
42
570
0.72
1.25
1.3
1.2
u/ml
155.5
218.1
0.24
36
529
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
13
70
1.87
1.24
1.1
1.1
g/l
1.6
1.5
0.33
13
64
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
108
1.68
1.23
1.4
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
19
2.64
1.21
1.2
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
14
79
1.78
1.17
5.8
1.7
%
56.8
61.7
0.27
14
79
(3004588) Protein electrophoresis panel - Serum or Plasma
55
422
1.32
1.16
2.8
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
39
2.06
1.15
1.4
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
64
503
1.29
1.14
3.4
3.7
%
0.7
0.6
0.14
18
71
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
68
539
1.28
1.14
2.2
2.4
ug/l
3.5
6.1
2.00
60
471
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
52
398
1.32
1.12
2.3
2.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
59
462
1.30
1.09
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.3
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
59
1.87
1.07
1.1
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
827
8084
1.22
1.07
13.7
8.5
u/l
23.9
22.8
0.91
805
7771
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
151
1313
1.18
1.06
4.3
3.7
ng/l
256.6
352.4
0.29
114
924
(3011412) CD3 cells [#/volume] in Blood
7
33
2.13
1.05
3.3
1.8
e9/l
1.3
1.5
—
7
17
(3034426) Prothrombin time (PT)
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
114
1.59
1.03
1.4
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
690
6658
1.14
1.01
26.9
14.8
g/l
330.5
330.9
0.72
680
6597
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
18
115
1.58
1.00
2.3
1.5
—
—
—
0
0
(4034850)
18
272
0.66
0.99
6.7
8.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
11
61
1.81
0.98
1.2
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
108
1.58
0.97
1.1
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
54
1.86
0.97
1.9
2.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
27
2.23
0.93
2.3
1.6
—
44.4
—
0
5
(21494890) Protein electrophoresis panel - 24 hour Urine
9
52
1.74
0.92
3.2
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
55
1.83
0.92
1.3
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
147
1664
0.86
0.91
1.5
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
86
1.64
0.91
1.1
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
110
1.56
0.91
5.6
1.3
—
—
—
0
0
(3013512) EKG study
215
1946
1.14
0.89
3.6
3.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
87
1.62
0.88
1.6
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
87
1.62
0.88
2.0
2.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
30
2.01
0.87
1.2
2.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
14
88
1.60
0.84
2.0
2.2
mmol/l
3.9
4.1
0.69
14
88
(3035285) Chloride [Moles/volume] in Venous blood
14
88
1.60
0.84
2.0
2.2
mmol/l
103.3
105.8
0.82
14
88
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
88
1.60
0.84
1.6
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
88
1.60
0.84
1.6
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
6
32
1.88
0.82
1.0
1.1
u/l
31.0
17.3
—
6
27
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
73
1.65
0.82
1.3
1.4
—
—
—
0
0
(3019225) pH of Specimen
81
685
1.20
0.81
4.7
3.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
233
1.34
0.80
4.2
1.4
g/l
3.4
3.1
0.71
26
192
(3044290) Cell count panel - Cerebral spinal fluid
9
151
0.59
0.79
1.1
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
21
291
0.72
0.77
1.3
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
37
470
0.78
0.76
1.2
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
59
1.70
0.76
1.6
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
54
1.67
0.74
1.2
1.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
44
353
1.26
0.73
1.5
1.3
u/ml
0.2
0.5
—
7
30
(3013707) Erythrocyte sedimentation rate by Westergren method
593
5722
1.10
0.72
4.3
4.2
mm/h
16.6
11.6
8.60
552
5328
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
60
1.67
0.72
2.2
1.8
pg
31.9
31.7
—
10
60
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
640
6594
0.90
0.72
4.9
4.5
pmol/l
14.8
14.6
0.76
594
6111
(40761511) CBC panel - Blood by Automated count
817
8027
1.15
0.70
18.6
10.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
77
1.57
0.68
1.2
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
61
1.65
0.68
1.2
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
110
1.46
0.68
1.6
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
43
528
0.81
0.68
2.9
2.7
e9/l
4.1
4.2
0.13
36
418
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
27
1.86
0.68
2.4
1.4
ug/l
8.0
8.7
—
5
27
(3026493) Urate [Moles/volume] in Serum or Plasma
187
1710
1.12
0.67
3.0
2.1
umol/l
7571.5
5992.3
0.13
158
1474
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
339
0.76
0.67
1.8
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
28
1.79
0.66
2.2
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
186
1703
1.12
0.65
1.5
1.5
nmol/l
20.0
22.0
1.08
165
1454
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
224
0.71
0.64
1.4
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
512
5310
0.92
0.62
3.3
3.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
130
1.39
0.61
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
18
244
0.73
0.61
1.1
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
52
1.54
0.59
3.1
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
114
1.41
0.59
1.3
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
109
974
1.14
0.58
1.8
1.9
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
149
1.35
0.58
3.2
2.4
ug/min
26.7
80.0
1.01
13
98
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
122
1100
1.13
0.57
1.8
2.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
14
195
0.71
0.56
1.1
1.3
mg/l
566.7
440.2
0.39
14
182
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
55
1.46
0.56
1.3
1.6
g/l
1.0
0.9
—
8
55
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
248
1.26
0.56
4.2
1.4
g/l
4.0
3.8
0.31
26
187
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
248
1.26
0.56
4.2
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
248
1.26
0.56
4.2
1.4
g/l
8.1
7.6
0.82
26
195
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
24
306
0.78
0.55
1.3
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
64
553
1.17
0.55
3.0
3.0
ng/l
294.9
192.2
0.70
59
505
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
78
885
0.87
0.54
1.3
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
38
1.58
0.54
1.5
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
44
368
1.21
0.54
1.6
1.9
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
18
134
1.35
0.53
3.4
2.8
mmol/l
7.2
7.5
0.20
18
129
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
62
1.46
0.53
1.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
19
144
1.33
0.51
3.3
2.7
mmol/l
1.5
1.5
0.00
19
139
(3002523) Influenza virus A Ag [Presence] in Specimen
10
145
0.69
0.51
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
115
1043
1.12
0.50
1.8
2.2
ug/g
85.3
118.6
1.19
90
811
(4094501)
14
190
0.73
0.50
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
84
1.43
0.49
1.6
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
144
0.69
0.49
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
144
0.69
0.49
1.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
85
1.42
0.47
1.6
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(4027681)
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
50
577
0.86
0.45
1.4
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
19
242
0.78
0.45
1.6
1.5
iu/ml
0.0
0.1
—
7
43
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
86
1.40
0.44
1.6
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
48
414
1.17
0.44
5.6
3.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
69
1.45
0.44
1.6
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
232
2191
1.08
0.44
2.2
2.1
u/l
146.9
143.4
0.06
220
2073
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
358
3435
1.07
0.44
2.5
2.3
nmol/l
75.6
78.5
1.27
325
3092
(3000475) Leukocytes [#/volume] in Synovial fluid
20
157
1.28
0.43
1.9
1.6
e6/l
19196.8
11218.5
0.26
15
115
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
262
0.80
0.43
2.0
1.9
iu/l
5.4
5.2
0.05
12
97
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
122
1.32
0.42
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
17
131
1.30
0.42
1.1
1.2
u/ml
1.6
5.6
—
8
48
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
17
131
1.30
0.42
1.0
1.1
u/ml
1.9
3.2
—
8
60
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
32
1.57
0.42
1.2
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(4133840)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
16
0.00
0.41
0.0
2.3
—
3.5
—
0
6
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
17
0.00
0.40
0.0
3.0
—
5.9
—
0
8
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
60
1.34
0.40
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
11
149
0.74
0.40
1.0
1.0
u/ml
8.1
2.5
—
5
77
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
321
3078
1.07
0.40
1.9
2.0
pmol/l
91.7
97.7
1.51
183
1488
(40765089) Chromosome analysis panel - Blood by G-banded
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
36
1.39
0.38
1.8
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
15
116
1.30
0.37
1.2
1.2
u/ml
320.4
236.6
—
10
77
(46235355) HIV 1 and 2 tests - Meaningful Use set
169
1589
1.08
0.37
1.7
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
145
1548
0.92
0.36
1.2
1.3
u/ml
19.0
12.6
0.42
63
624
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
17
212
0.80
0.36
1.2
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.7
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
64
576
1.12
0.35
6.0
3.1
ng/l
108.1
79.1
1.18
59
508
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
16
127
1.26
0.33
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
210
1.20
0.33
1.2
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
391
3796
1.05
0.31
3.0
2.8
ug/l
165.6
75.0
7.38
364
3541
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
52
1.35
0.31
1.1
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
29
249
1.17
0.31
1.1
1.1
u/ml
2.5
7.0
—
5
37
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
65
713
0.90
0.30
1.4
1.2
iu/ml
121.5
141.2
0.21
20
286
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
54
1.30
0.30
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
93
1.29
0.30
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
163
0.79
0.29
1.0
1.1
u/ml
0.2
2.0
—
5
63
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
7
56
1.25
0.29
1.0
1.1
mg/l
203.9
200.5
—
7
48
(3008898) HLA-B27 [Presence]
30
345
0.87
0.29
1.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
155
1634
0.94
0.29
1.7
1.7
pmol/l
55147538.0
24346374.9
0.23
136
1376
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
121
1.24
0.28
2.7
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
21
248
0.84
0.28
1.6
1.7
—
—
—
0
0
(4024509)
10
76
1.32
0.28
2.1
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
166
1579
1.06
0.28
1.5
1.3
g/l
2.3
2.2
0.13
111
935
(3024891) Influenza virus A+B Ag [Presence] in Specimen
25
215
1.17
0.27
1.1
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
850
8555
0.92
0.26
31.2
16.7
e12/l
4.2
4.4
23.01
831
8307
(3035941) MCH [Entitic mass]
850
8555
0.92
0.26
31.0
16.6
pg
30.1
30.1
0.26
841
8423
(3024731) MCV [Entitic volume]
850
8554
0.92
0.25
31.1
16.6
fl
91.1
90.7
1.30
842
8423
(3032773) Endomysium IgG Ab [Titer] in Serum
6
81
0.74
0.24
1.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
6
83
0.72
0.24
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
32
284
1.13
0.24
1.3
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
224
2162
1.05
0.23
3.0
3.0
mmol/l
6.3
6.6
0.69
191
1835
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
66
710
0.92
0.22
1.8
1.7
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
95
0.73
0.22
1.6
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
178
0.84
0.22
1.7
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
851
8558
0.93
0.21
31.2
16.7
e9/l
6.5
6.7
1.06
833
8306
(3034891) Synovial lining cells/100 cells in Synovial fluid
5
42
1.19
0.21
1.2
1.3
—
8.0
—
0
7
(3007461) Platelets [#/volume] in Blood
850
8548
0.93
0.21
31.2
16.7
e9/l
254.6
264.4
4.64
834
8325
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
262
0.87
0.21
1.1
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
16
188
0.85
0.21
2.6
2.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
8
102
0.78
0.21
1.8
1.5
—
16.8
—
0
5
(3000963) Hemoglobin [Mass/volume] in Blood
851
8557
0.93
0.21
31.3
16.8
g/l
126.4
132.4
30.13
843
8429
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.3
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
48
1.25
0.20
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
26
292
0.89
0.20
2.1
1.8
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
9
113
0.79
0.20
1.1
1.2
nmol/l
—
0.4
—
0
8
(3009466) Valproate [Moles/volume] in Serum or Plasma
9
115
0.78
0.20
6.4
5.4
umol/l
387.8
368.9
—
9
95
(1761868) Lipid panel - Serum or Plasma
266
2733
0.96
0.19
2.6
2.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
23
259
0.89
0.18
1.8
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.7
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
217
0.87
0.18
1.3
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
59
1.19
0.18
1.0
3.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
7
62
1.13
0.17
1.1
1.2
mg/l
27.4
30.5
—
7
52
(3014051) Protein [Presence] in Urine by Test strip
18
205
0.88
0.17
1.8
2.1
—
—
—
0
0
(4146454)
5
67
0.74
0.17
1.8
2.9
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
8
71
1.13
0.16
1.1
1.1
—
75.9
—
0
7
(3037522) Nuclear Ab [Titer] in Serum
121
1163
1.05
0.16
1.5
1.3
titre
743.3
641.2
0.18
24
271
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
11
92
1.20
0.16
1.5
1.6
%
60.0
59.4
—
5
55
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
69
729
0.94
0.16
1.5
1.5
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
8
72
1.11
0.16
1.1
1.1
—
49.3
—
0
6
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
78
0.77
0.15
2.7
2.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
48
513
0.93
0.15
1.4
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
207
2017
1.03
0.14
3.1
3.1
mg/l
884.2
245.6
0.79
138
1174
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
86
0.81
0.14
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
131
1.15
0.14
1.5
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
274
0.91
0.14
1.8
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
14
122
1.15
0.13
1.1
1.4
mmol/l
9.6
7.6
—
7
88
(3000492) Spirometry study
66
694
0.95
0.13
1.6
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
128
0.86
0.13
1.4
1.2
—
—
—
0
0
(4010399)
49
520
0.94
0.13
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
107
0.84
0.13
1.1
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
703
7078
0.97
0.12
21.7
12.4
%
37.9
39.0
3.22
513
5206
(4268621)
10
85
1.18
0.12
2.2
2.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
134
1.12
0.11
1.7
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
125
1.12
0.10
1.1
1.2
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
5
44
1.14
0.10
1.4
1.1
u/l
164.0
528.4
—
5
39
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
45
1.11
0.10
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
52
543
0.96
0.09
1.6
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
196
0.92
0.09
1.3
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
134
0.89
0.08
1.1
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
64
0.78
0.08
1.4
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
98
1.12
0.07
1.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
72
0.83
0.07
1.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
82
0.85
0.07
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
85
0.82
0.07
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
214
2115
1.02
0.05
4.3
3.7
mg/mmol
26.6
7.1
2.40
144
1237
(3027008) Opiates [Presence] in Urine
26
273
0.95
0.05
1.8
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
110
0.91
0.05
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
53
545
0.97
0.05
2.7
3.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
26
272
0.95
0.04
1.8
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
74
754
0.98
0.04
1.5
1.6
%
1.5
1.3
1.71
67
668
(40768797) Stomach Pathology biopsy report
107
1056
1.01
0.03
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
192
1936
0.99
0.03
1.4
1.3
u/ml
0.6
1.8
2.74
71
520
(3027944) Amphetamines [Presence] in Urine
26
268
0.97
0.02
1.8
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
298
0.97
0.02
1.6
1.3
miu/ml
247.9
223.7
0.14
15
152
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
155
1559
0.99
0.01
1.3
1.3
iu/ml
42.0
34.6
0.18
57
502
(3044941) Cell count panel - Synovial fluid
12
114
1.05
0.00
1.7
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
106
1.04
0.00
1.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
116
1.03
0.00
1.1
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
24
244
0.98
0.00
1.6
1.2
u/ml
29.5
9.2
—
5
47
(4306422)
12
118
1.02
0.00
1.3
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
140
1395
1.00
0.00
1.8
1.7
nmol/l
1268.0
1206.5
0.31
111
1041
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
107
1.03
0.00
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
121
0.99
0.00
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
217
1.01
0.00
1.4
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
80
805
0.99
0.00
1.4
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
5.3
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
80
1.00
0.00
1.1
1.7
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
8.9
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
59
0.85
0.00
1.4
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.9
—
0
5
(3051339) Copper [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
16.9
—
0
6
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(4062490)
8
81
0.99
0.00
1.4
1.5
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
130
1.00
0.00
1.5
1.9
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
64
0.94
0.00
1.0
1.2
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
181.4
—
0
5
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
64
0.94
0.00
1.0
1.2
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
5
49
1.02
0.00
4.0
1.4
u/l
5.1
6.3
—
5
41
(3017509) Phencyclidine [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
100
1.00
0.00
1.0
1.2
nmol/l
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
68
0.88
0.00
1.3
1.3
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
3.8
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
62
0.97
0.00
3.3
3.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
62
0.97
0.00
1.0
1.9
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_CERVIX_UTERI_EXALLC – Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).